StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.21−0.10 (-3.02%)

Close on Nov 17, 2026Market cap $28.79MP/E –Yield –

ProMIS Neurosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

ProMIS Neurosciences's pe ratio was 7.3× on Apr 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20257.3×–

More ProMIS Neurosciences figures

See a number that looks wrong?